THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an important role in anti-viral and anti-tumor protection. At the same time, they possess a pronounced immune-modulating, anti-proliferative and anti-fibrotic effect. A general comparative characteristic of hum...

Full description

Bibliographic Details
Main Authors: T. P. Ospelnikova, E. M. Noseikina, L. A. Gaiderova, F. I. Ershov
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2016-10-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.elpub.ru/jour/article/view/94
_version_ 1818081119940116480
author T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov
author_facet T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov
author_sort T. P. Ospelnikova
collection DOAJ
description Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an important role in anti-viral and anti-tumor protection. At the same time, they possess a pronounced immune-modulating, anti-proliferative and anti-fibrotic effect. A general comparative characteristic of human IFN type I (a/(3), IFN type II (y) and IFN type III (X) and nosological directionality of contemporary drugs created on their base is examined in the review. Epidemiologic parameters for main socially-significant human diseases of viral etiology are presented: influenza and other ARVis, herpes infection, chronic viral hepatitis В, C and D. Main attention is given to analysis of effectiveness of therapeutic application of preparations based on IFNa during the indicated infections, a specter of main IFNa induced side effects is listed. Recent achievements on the path of creation of principally new drugs based on IFN, that have lower toxicity and higher clinical effectiveness, as well as perspectives of application of preparations based on recombinant IFN for therapy of potentially dangerous diseases are examined.
first_indexed 2024-12-10T19:01:09Z
format Article
id doaj.art-f0371d714ae9419db6c045d1870ecabd
institution Directory Open Access Journal
issn 0372-9311
2686-7613
language Russian
last_indexed 2024-12-10T19:01:09Z
publishDate 2016-10-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj.art-f0371d714ae9419db6c045d1870ecabd2022-12-22T01:37:01ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132016-10-010510912110.36233/0372-9311-2016-5-109-12194THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGYT. P. Ospelnikova0E. M. Noseikina1L. A. Gaiderova2F. I. Ershov3Gamaleya Federal Research Centre of Epidemiology and MicrobiologyA11-Russian Scientific Centre for Safety of Biologically Active SubstancesScientific Centre of Expertise of Means for Medical UseGamaleya Federal Research Centre of Epidemiology and MicrobiologyInterferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an important role in anti-viral and anti-tumor protection. At the same time, they possess a pronounced immune-modulating, anti-proliferative and anti-fibrotic effect. A general comparative characteristic of human IFN type I (a/(3), IFN type II (y) and IFN type III (X) and nosological directionality of contemporary drugs created on their base is examined in the review. Epidemiologic parameters for main socially-significant human diseases of viral etiology are presented: influenza and other ARVis, herpes infection, chronic viral hepatitis В, C and D. Main attention is given to analysis of effectiveness of therapeutic application of preparations based on IFNa during the indicated infections, a specter of main IFNa induced side effects is listed. Recent achievements on the path of creation of principally new drugs based on IFN, that have lower toxicity and higher clinical effectiveness, as well as perspectives of application of preparations based on recombinant IFN for therapy of potentially dangerous diseases are examined.https://microbiol.elpub.ru/jour/article/view/94influenzachronic hepatitisherpes virus infectioninterferonsifna therapy
spellingShingle T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov
THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
Журнал микробиологии, эпидемиологии и иммунобиологии
influenza
chronic hepatitis
herpes virus infection
interferons
ifna therapy
title THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
title_full THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
title_fullStr THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
title_full_unstemmed THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
title_short THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY
title_sort therapeutic potential of alpha interferon preparations during socially significant human diseases of viral etiology
topic influenza
chronic hepatitis
herpes virus infection
interferons
ifna therapy
url https://microbiol.elpub.ru/jour/article/view/94
work_keys_str_mv AT tpospelnikova therapeuticpotentialofalphainterferonpreparationsduringsociallysignificanthumandiseasesofviraletiology
AT emnoseikina therapeuticpotentialofalphainterferonpreparationsduringsociallysignificanthumandiseasesofviraletiology
AT lagaiderova therapeuticpotentialofalphainterferonpreparationsduringsociallysignificanthumandiseasesofviraletiology
AT fiershov therapeuticpotentialofalphainterferonpreparationsduringsociallysignificanthumandiseasesofviraletiology